new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Diacylglycerol O-acyltransferase 1 (DGAT1)' and Ligand = 'BDBM50438712'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Diacylglycerol O-acyltransferase 1 (DGAT1)


(Homo sapiens (Human))
BDBM50438712
PNG
(CHEMBL2414697)
Show SMILES CN(CC(O)=O)C(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)N1CCOc2ncnc(N)c2C1=O |r,wU:12.15,wD:9.8,(30.02,-40.47,;28.5,-40.16,;28.01,-38.69,;29.03,-37.54,;30.54,-37.84,;28.54,-36.06,;27.48,-41.32,;27.98,-42.8,;25.97,-41.01,;24.93,-42.19,;23.45,-41.92,;22.44,-43.07,;22.92,-44.51,;24.42,-44.82,;25.44,-43.67,;21.88,-45.69,;22.38,-47.18,;21.37,-48.32,;19.87,-48.02,;19.39,-46.57,;20.4,-45.43,;18.83,-49.2,;19.46,-50.64,;18.73,-52,;17.2,-52.28,;16.04,-51.26,;14.67,-51.98,;13.35,-51.15,;13.43,-49.6,;14.79,-48.88,;14.86,-47.34,;16.1,-49.72,;17.35,-48.8,;17.07,-47.28,)|
Show InChI InChI=1S/C24H29N5O5/c1-28(13-20(31)32)19(30)12-15-2-4-16(5-3-15)17-6-8-18(9-7-17)29-10-11-34-23-21(24(29)33)22(25)26-14-27-23/h6-9,14-16H,2-5,10-13H2,1H3,(H,31,32)(H2,25,26,27)/t15-,16-
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 26n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry


Bioorg Med Chem 21: 5081-97 (2013)


Article DOI: 10.1016/j.bmc.2013.06.045
BindingDB Entry DOI: 10.7270/Q26111RG
More data for this
Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (DGAT1)


(Homo sapiens (Human))
BDBM50438712
PNG
(CHEMBL2414697)
Show SMILES CN(CC(O)=O)C(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)N1CCOc2ncnc(N)c2C1=O |r,wU:12.15,wD:9.8,(30.02,-40.47,;28.5,-40.16,;28.01,-38.69,;29.03,-37.54,;30.54,-37.84,;28.54,-36.06,;27.48,-41.32,;27.98,-42.8,;25.97,-41.01,;24.93,-42.19,;23.45,-41.92,;22.44,-43.07,;22.92,-44.51,;24.42,-44.82,;25.44,-43.67,;21.88,-45.69,;22.38,-47.18,;21.37,-48.32,;19.87,-48.02,;19.39,-46.57,;20.4,-45.43,;18.83,-49.2,;19.46,-50.64,;18.73,-52,;17.2,-52.28,;16.04,-51.26,;14.67,-51.98,;13.35,-51.15,;13.43,-49.6,;14.79,-48.88,;14.86,-47.34,;16.1,-49.72,;17.35,-48.8,;17.07,-47.28,)|
Show InChI InChI=1S/C24H29N5O5/c1-28(13-20(31)32)19(30)12-15-2-4-16(5-3-15)17-6-8-18(9-7-17)29-10-11-34-23-21(24(29)33)22(25)26-14-27-23/h6-9,14-16H,2-5,10-13H2,1H3,(H,31,32)(H2,25,26,27)/t15-,16-
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 421n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addi...


Bioorg Med Chem 21: 5081-97 (2013)


Article DOI: 10.1016/j.bmc.2013.06.045
BindingDB Entry DOI: 10.7270/Q26111RG
More data for this
Ligand-Target Pair